PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
View ORCID ProfileLorenz Kocheise, View ORCID ProfileIgnazio Piseddu, Joscha Vonderlin, Eric T Tjwa, View ORCID ProfileGustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro-Barciela, View ORCID ProfileTom JG Gevers, View ORCID ProfileBenedetta Terziroli Beretta-Piccoli, View ORCID ProfileMaria-Carlota Londoño, View ORCID ProfileSona Frankova, Thomas Roesner, Vincent Joerg, View ORCID ProfileConstantin Schmidt, Fabian Glaser, Jan P Sutter, Thorben W Fründt, Ansgar W Lohse, View ORCID ProfileSamuel Huber, View ORCID ProfileJohann von Felden, Marcial Sebode, Kornelius Schulze
doi: https://doi.org/10.1101/2023.07.17.23292183
Lorenz Kocheise
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Ignazio Piseddu
2Department of Internal Medicine II, University Hospital, LMU Munich, Munich, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Joscha Vonderlin
3Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Eric T Tjwa
4Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Gustav Buescher
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Lucy Meunier
5Service Hépato-Gastro Entérologie, Hôpital St-Eloi, CHU Montpellier, France
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Pia Goeggelmann
6Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany
Francesca Fianchi
7CEMAD-Centro Malattie dell’Apparato Digerente. Fondazione Policlinico Universitario Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Jérôme Dumortier
8Service d’hépato-gastroentérologie, Hôpital Edouard Herriot – Hospices civils de Lyon, and Université de Lyon, Lyon, France
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Mar Riveiro-Barciela
9Liver Unit, Department of Internal Medicine, Hospital Universitari Valle d’Hebron, Vall d’Hebron Barcelona Hospital Campus; Universitat Autònoma de Barcelona, Barcelona, Spain; CIBERehd
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Tom JG Gevers
10Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands
11Nutrim School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Benedetta Terziroli Beretta-Piccoli
12Epatocentro Ticino, Lugano, Switzerland
13Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Maria-Carlota Londoño
14Liver Unit, Hospital Clinic Barcelona, FCRB-IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Sona Frankova
15Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Thomas Roesner
16Department of Medical Oncology, National Center of Tumor Diseases (NCT) Heidelberg and Universitätsklinikum Heidelberg, Heidelberg, Germany
Vincent Joerg
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Constantin Schmidt
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Fabian Glaser
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Jan P Sutter
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Thorben W Fründt
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Ansgar W Lohse
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Samuel Huber
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Johann von Felden
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Marcial Sebode
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Kornelius Schulze
1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
17European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Data availability
All data relevant to the study are included in the article.
Posted July 18, 2023.
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, Eric T Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro-Barciela, Tom JG Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Jan P Sutter, Thorben W Fründt, Ansgar W Lohse, Samuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze
medRxiv 2023.07.17.23292183; doi: https://doi.org/10.1101/2023.07.17.23292183
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, Eric T Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro-Barciela, Tom JG Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Jan P Sutter, Thorben W Fründt, Ansgar W Lohse, Samuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze
medRxiv 2023.07.17.23292183; doi: https://doi.org/10.1101/2023.07.17.23292183
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)